References
- Rau JL. The inhalation of drugs: advantages and problems. Resp Care. 2005;50(3):367–382. •• One of the first critical (comparative) evaluations regarding the efficacy of pulmonary drug delivery devices.
- Anderson PJ. History of aerosol therapy: liquid nebulization to MDIs to DPIs. Resp Care. 2005;50(9):1139–1150.
- Sanders M. Inhalation therapy: an historical review. Prim Care Resp J. 2007;16(2):71–81.
- Sehata M. History of inhalation iherapy. Internet J Health. 2008;9(1):1–9.
- Stein WS, Thiel CG. The history of therapeutic aerosols: a chronical review. J Aerosol Med Pulm Drug Deliv. 2017;30(1):20–41.
- Rudén J. Powder mechanics and dispersion properties of adhesive mixtures for dry powder inhalers, conceptualized as a blend state model [Thesis]. Sweden: University of Uppsala, Dept Pharm Bioscience, 2021, pp 16–21.
- Rospond B, Krakowska A, Muszyńska B, et al. The history, current state and perspectives of aerosol therapy. Acta Pharm. 2022;72(2):225–243.
- Prime D, Atkins PJ, Slater A, et al. Review of dry powder inhalers. Adv Drug Deliv Rev. 1997;26(1):51–58.
- Newman SP, Busse WW. Evolution of dry powder inhaler design, formulation, and performance. Resp Med. 2002;96(5):293–304.
- Atkins PJ. Dry powder inhalers: an overview. Resp Care. 2005;50(10):1304–1312.
- Young PM, Traini D, Coates M, et al. Dry powder inhalers: challenges and goals for next generation therapies. Pharm Tech Europe. 2007;19(4):1–17.
- Reddy SC. Past and present trends of dry powder inhaler devices: a review. J Drug Deliv Therapeutics. 2014;4(1):97–107.
- Berkenfeld K, Lamprecht A, McConville, et al. Devices for dry powder drug delivery to the lung. AAPS PharmSciTech. 2015;16(3):479–490.
- de Boer AH, Hagedoorn P, Hoppentocht M, et al. Dry powder inhalation: past, present and future. Exp Opion Drug Deliv. 2017;14(4):499–512.
- Metha PP. Dry powder inhalers: upcoming platform technologies for formulation development. Ther Deliv. 2019;10(9):551–554.
- Xiroudaki S, Schoubben A, Giovagnoli S, et al. Dry powder inhalers in the digitalization era: current status and future perspectives. Pharmaceutics. 2021;13(9):1455.
- Dolgin E. The tangled history of mRNA vaccines. Nature. 2021;597(7876):318–324.
- Sahin U, Karikó K, Türeci Ö. mRNA-based therapeutics – developing a new class of drugs. Nat Rev Drug Discov. 2014;13(10):759–780.
- Lagendijk VC. Electrifying Europe: the power of Europe in the construction of electricity networks. Thesis Techn. The Netherlands: University Eindhoven, 2008, pp. 15–104.
- Chalmin P. The history of plastics: from the capitol to the Tarpeian rock. Open Edition J. 2019;19:6–11.
- Maglione M, Miotto K, Iguchi M, et al. Psychiatric effects of Ephedra use: an analysis of food and drug administration reports of adverse events. Am J Psychiatry. 2005;162(1):189–191.
- Miller SC. Psychiatric effects of Ephedra: addiction. Am J Psychiatry. 2005;162(11):2198.
- Sheik Ali B, Sathiswara B. Atropine induced psychosis: a report of two cases. Int J Health Sci Res. 2017;7(12):325–327.
- Picciotto MR, Kenny PJ. Mechanisms of nicotine addiction. Cold Spring Harb Perspect Med. 2021;11(5):a039610.
- Charlton A. Medicinal uses of tobacco in history. J R Soc Med. 2004;97(6):292–296.
- Jackson M. “Devine Stramonium”: the rise and fall of smoking for asthma. Med Hist. 2010;54(2):171–194.
- Wasik AA, Tuuminen T. Salt therapy as a complementary method for the treatment of respiratory tract diseases, with a focus on mold-related illness. Altern Ther Health Med. 2021;27(S1):223–239.
- Antonelli M, Donelli D, Barbieri G, et al. Forest volatile organic compounds and their effects on human health: a state-of-the-art review. Int J Environ Res Public Health. 2020;17(18): 6506.
- Miller WF. Aerosol therapy in acute and chronic respiratory disease. Arch Intern Med. 1973;131(1):148–155.
- Dessanges J-F. A history of nebulization. J Aerosol Med. 2001;14(1):65–71.
- Barberis I, Bragazzi NL, Galluzzo L, et al. The history of tuberculosis: from the first historical records to the isolation of Koch’s bacillus. J Prev Med Hyg. 2017;58(1):E9–12.
- Lee MK, Cheng BW, Che CT, et al. Cytotoxicity assessment of Ma-Huang (Ephedra) under different conditions of preparation. Toxicol Sci. 2000;56(2):424–430.
- Jiao, Jao J, Wu J, et al. Ma Huang Tang ameliorates bronchial asthma symptoms through the TLR9 pathway. Pharm Biol. 2018;56(1):580–593.
- Veith I. The yellow emperor’s classic of internal medicine. Berkeley and Los Angeles: University of California Press; 1966.
- ItsHaky B. Huang Di Nei Jing Ling Shu; The ancient classic on needle therapy; the complete Chinese text with an annotated English translation. J Altem Complement Integr Med. 2017;3:20.
- Kan LB. Introduction to Chinese medical literature. Bull Med Libr Assoc. 1965;53(1):60–67.
- Watson B. Ssu-ma Ch’ien Grand historian of China. New York: Columbia University Press; 1963.
- Chi-min W. China’s contribution to medicine in the past. Annals of Medical History. 1926;VIII:192–201.
- Metwaly AM. Traditional ancient Egyptian medicine: a review. Saudi J Biological Sci. 2021;28(10):5823–5832.
- Ebbel B. The Papyrus Ebers, the greatest Egyptian medical document. Copenhagen: Levin & Munksgaard; 1937.
- Popko L, Schneider UJ, Scholl R, et al. Papyrus Ebers: Die grösste Schriftrolle zur altägyptischen Heilkunst. Darmstadt: WBG; 2021. • Very interesting renewed translation of the Papyrus Ebers with annotations (in German).
- Cohen SG. Asthma in antiquity: the Ebers Papyrus. Allergy Proc. 1992;13(3):147–154.
- Karamanou M, Androutsos G. Aretaeus of Cappadocia and the first clinical description of asthma, letter to the editor. Am J Respir Crit Care Med. 2011;184(12):1420–1421.
- Alizadeh A, Moshiri M, Alizadeh J, et al. Black henbane and its toxicity – a descriptive review. Avicenna J Phytomed. 2014;4(5):297–311.
- Raju VK. Susruta of ancient India. Indian J Ophthalmol. 2003;51(2):119–122.
- Loukas M, Lanteri A, Ferrauiola J, et al. Anatomy in ancient India: a focus on the Susruta Samhita. J Anat. 2010;217(6):646–650.
- Panda AK, Doddanagali SR. Clinical efficacy of herbal Padmapatradi yoga in bronchial asthma (Tamaka Swasa). J Ayurveda Integrative Med. 2011;2(2):85–90.
- Patwardhan K. The history of the discovery of blood circulation: unrecognized contributions of ayurveda masters. Adv Physiol Educ. 2012;36(2):77–82.
- Bhavana KR, Shreevathsa S. Medical geography in Charaka Samhita. AYU Int Q J Res Ayurveda. 2014;35(4):371–377.
- Mukherjee PK, Harwansh RK, Bahadur S, et al. Development of ayurveda - tradition to trend. J Ethnopharmacol. 2017;197:10–24.
- Meulenbeld GJ. A history of Indian medical literature, part 1A, Vol 1. Brill/Schöningh Verlag: Paderborn; 2002.
- Pappas G, Kiriaze IJ, Falagas ME, et al. Insights into infectious disease in the era of Hippocrates. Int J Infect Disease. 2008;12(4):347–350.
- Redman Coxe J. The writings of Hippocrates and Galen, epitomised from the original latin translations. Philadelphia: Lindsay and Blakiston; 1846. •• Highly interesting commentary on translated medical treatises written by Hippocrates (of Kos) and Claudius Galenus to those admiring ancient Greek medical knowledge.
- Brownstein, Brownstein KJ, Tushingham S, et al. An ancient residue metabolomics-based method to distinguish use of closely related plant species in ancient pipes. Front Mol Biosci. 2020;7:133.
- Saxena G, McCutcheon AR, Farmer S, et al. Antimicrobial constituents of Rhus glabra. J Ethnopharmacol. 1994;43(2):95–99.
- Sanchez-Ramos JR. The rise and fall of tobacco as a botanical medicine. J Herbal Med. 2020;22:100374.
- Proctor RN. The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll. Tob Control. 2012;21(2):87–91.
- Ren M, Tang Z, Wu X, et al. The origins of cannabis smoking: chemical residue evidence from the first millennium BCE in the Pamirs. Sci Adv. 2019;5(6):eaaw1391.
- Amr SS, Tbakhi A. Abu Bakr Muhammad Ibn Zakariya Al Razi (Rhazes): philosopher, physician and alchemist. Ann Saudi Med. 2007;27(4):305–307.
- McCall T. Medical knowledge in the early medieval period. British Library. 2021. [cited Dec 2021]. Available from: https://www.bl.uk/medieval-english-french-manuscripts/articles/medical-knowledge-in-the-early-medieval-period?
- Wishah G. Ibn Sina’s role in scientific discoveries. Asian J Humanities Social Studies. 2018;6(6):193–200.
- Gea J. Maimonides, the respiratory system and personalized medicine. Open Respir Arch. 2019;1(1–2):3–4.
- Cohen SG. Food allergens: landmarks along a historic trail. J Allergy Clin Immunol. 2008;121(6):1521–1524.
- Zaikon SJ. Maimonides 1135-1204. Q Bull Northwest Univ Med Sch. 1959;33(1):71–76.
- Beyar R, Skorecki K, Blazer S. The Maimonides heritage: discovery and propagation of medical knowledge. Rambam Maimonides Med J. 2018;9(3):e0017.
- Miller MJ, Albarracin-Jordan J, Moore C, et al. Chemical evidence for the use of multiple psychotropic plants in a 1,000-year-old ritual bundle from South America. PNAS. 2019;116(23):11207–11212.
- Newton AV. Inhaling apparatus. English patent 1161. 1964
- Hassall AH. The inhalation treatment of diseases of the organs of respiration: including consumption. London: Longmans, Green, and Co; 1885.
- McGinnis JD, Carlill V. Carbolic smoke ball company: influenza, quackery, and the unilateral contract. Can Bull Med Hist. 1988;5:121–141, CBMH/BCHM
- Farber JE, Ross J. The use of aerosol Penicillin and Streptomycin in bronchopulmonary infections. Calif Med. 1950;73(3):214–217.
- Svizzero S. Persistent controversies about the Neolithic revolution. J Hs Arch & Anthropol Sci. 2017;1(2):53–56. •• Critical evaluation of the debates about the presumed superiority of farming over foraging and the origin and spread of the Neolithic revolutions.
- Smith ME. Gordon childe and the Urban revolution: a historical perspective on a revolution in urban studies. Trp. 2009;80(1):3–29.
- McFadden ER. A century of asthma. Am J Respir Crit Care Med. 2004;170(3):215–221.
- Blevins SM, Bronze MS. Robert Koch and the ‘golden age’ of bacteriology. Int J Infect Diseases. 2010;14(9):e744–e51.
- Münch R. Robert Koch. Microbes Infect. 2003;5(1):69–74.
- Williams DW. The germs-theory. Br Med J. 1871 April;8(536):368.
- Gaynes R. The discovery of Penicillin – new insights after more than 75 years of clinical use. Emerging Infect Dis. 2017;23(5):849–853.
- Zaitlin M. The discovery of the causal agent of the tobacco Mosaic disease. In: Kung SD, Yang SF, editors. Discoveries in plant biology. Hong Kong: World Publishing Co. Ltd; 1998. p. 105–110.
- Pirofski L-A, Casadevall A. What is infectiveness and how is it involved in infection and immunity? BMC Immunol. 2015;16(1):13.
- Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–433.
- Gygli SM, Borrell S, Trauner A, et al. Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives. FEMS Microbiol Rev. 2017;41(3): 354–373.
- Traini D, Young PM. Drug delivery for tuberculosis: is inhaled therapy the key to success? Ther Deliv. 2017;8(10):819–821.